Remiges Biopharma Fund, LP
Remiges Ventures · adviser of record: Remiges Ventures, Inc. · 2014 vintage
Remiges Biopharma Fund, LP is a 2014 venture fund managed by Remiges Ventures, with $80mm raised (Form D, amount sold). It reported $80mm in gross assets at year-end 2025, 1.00x its size, against a peak of $80mm in 2016.
- Latest value held
- $80mm year-end 2025
- Peak
- $80mm year-end 2016
- Fund size
- $80mm Form D, amount sold
- Held vs. size
- 1.00x peak 1.00x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $80mm | 1.00x | +0% over 2 yrs |
| 2023 | $80mm | 1.00x | +0% |
| 2022 | $80mm | 1.00x | +0% |
| 2021 | $80mm | 1.00x | +0% |
| 2020 | $80mm | 1.00x | +0% |
| 2019 | $80mm | 1.00x | +0% |
| 2018 | $80mm | 1.00x | +0% |
| 2017 | $80mm | 1.00x | +0% |
| 2016 | $80mm | 1.00x | +14% |
| 2015 | $70mm | 0.88x | +0% |
| 2014 | $70mm | 0.88x | – |
Other funds from Remiges Ventures
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-6741656208. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.